Focused radiation boost for locally advanced prostate cancer
Part of Cancer, Kidney & urinary clinical trials.
This trial tests whether adding an extra, focused dose of radiation to the visible tumor during MRI-guided radiotherapy can better treat locally advanced prostate cancer. It aims to improve cancer control while limiting side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man aged 18 or older
- You have prostate cancer confirmed by biopsy
- Your MRI shows the tumor has grown just outside the prostate (stage T3b) but has not spread to lymph nodes or other organs
- You have a visible tumor spot on MRI
- You have not had radiation to the pelvic area or prostate surgery (TURP) in the past
- You can have an MRI and lie still for 45–60 minutes
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new, shorter course of radiation for intermediate-risk prostate cancer. It aims to give a higher dose to the main tumor while keeping side effects low.
This trial tests a newer, more precise radiation treatment that gives a higher dose to the main tumor while keeping radiation to the rest of the prostate the same. It is for men with intermediate- or high-risk prostate cancer who haven't had prior prostate radiation or removal.
This trial tests a shorter course of radiation therapy with an extra 'boost' to the most aggressive part of the tumor, combined with hormone therapy, for men with high-risk or locally advanced prostate cancer that has not spread outside the pelvis.
This trial tests a special type of radiation therapy (SBRT) that delivers a higher dose directly to the main tumor in your prostate, guided by a PSMA PET scan. It aims to improve cancer control while limiting side effects.
This trial studies whether giving a moderate “boost” dose of radiation to the prostate—along with radiation to the pelvic area—can better control high-risk localized prostate cancer. You may benefit if you have high-risk disease and can safely receive radiation.
This trial tests a more concentrated radiation schedule for early-stage prostate cancer, using an extra high-dose “boost” delivered from inside the body. It may help by treating the prostate more precisely while aiming to keep side effects manageable.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.